Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002496:Central Venous Pressure / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D005260:Female; D006321:Heart / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D007263:Infusions, Parenteral; D008297:Male; D008790:Metoprolol / Q000008:administration & dosage / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D011217:Practolol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D011294:Prenalterol; D011412:Propanolamines / Q000037:antagonists & inhibitors*; D011669:Pulmonary Wedge Pressure / Q000187:drug effects; D013318:Stroke Volume / Q000187:drug effects; D014655:Vascular Resistance / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D011412:Propanolamines; D008790:Metoprolol; D011294:Prenalterol; D011217:Practolol